Correction to: Axillary surgery versus no-axillary staging in T1N0 breast cancer: 20-year follow-up of the INT 09/98 randomized clinical trial - Takeaways - MDSpire

Correction to: Axillary surgery versus no-axillary staging in T1N0 breast cancer: 20-year follow-up of the INT 09/98 randomized clinical trial

  • November 6, 2025

  • 0 min

Share

  • 1

    The erratum corrects the abstract of a study on axillary surgery and non-axillary staging in T1N0 breast cancer.

  • 2

    The role of axillary surgery has evolved to a staging method for adjuvant therapies, emphasizing sentinel lymph node biopsy.

  • 3

    The incidence of distant metastases in patients with axillary recurrence indicates aggressive primary tumor biology.

  • 4

    The corrected conclusion highlights a biologically aggressive subgroup with poorer prognosis among patients with axillary recurrence.

  • 5

    The erratum clarifies findings from a two-decade follow-up of the INT 09/98 randomized clinical trial.

Original Source(s)

Correction to: Axillary surgery versus no-axillary staging in T1N0 breast cancer: 20-year follow-up of the INT 09/98 randomized clinical trial

  • November 6, 2025

Related Content

Advancements in Nerve Block Techniques for Breast Surgery: From Efficacy Comparisons to Comprehensive Assessment and Targeted Applications

Efficacy and safety of hypofractionated versus conventional radiotherapy in breast cancer: a systematic review and meta-analysis

Cosmetic outcomes of oncoplastic surgeries in breast cancer patients: an eleven-year experience from two tertiary referral centers